CTOs on the Move

Checkmate Pharmaceuticals

www.checkmatepharma.com

 
It has exclusively licensed a clinically validated virus-like particle (VLP) platform from Cytos Biotechnology Ltd (SIX:CYTN) for the field of oncology, that includes the clinical product (CYT003) and technologies related to oligonucleotide synthesis and VLP delivery. CYT003 is a product derived from the CpG class of oligonucleotides that activates the immune system via Toll-like receptor 9 (TLR9) and has the potential to improve efficacy outcomes and broaden the size of the populations that can benefit from checkpoint inhibitor therapies.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Can't execute query

select mm.personal_id,pm.first_name,pm.last_name,mm.title from cto_movement_master as mm, cto_personal_master as pm where mm.personal_id=pm.personal_id and mm.company_id='544194' order by mm.personal_id desc limit 0,5

MySQL Error: MySQL server has gone away

This script cannot continue, terminating.